Showing results (481-490 of 630) with videos related to

Sort By:
Pageof 63
Dermatitis : Contact, Atopic, Occupational, Drug|April 2, 2021
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With AbrocitinibEric L Simpson, Andreas Wollenberg, Robert Bissonnette, et al.
American Journal of Clinical Dermatology|August 18, 2021
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial ProgramEric L Simpson, Jonathan I Silverberg, Audrey Nosbaum, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 19, 2016
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus OpinionJennifer K Chen, Sharon E Jacob, Susan T Nedorost, et al.
The Journal of Investigative Dermatology|November 4, 2018
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult PopulationZelma C Chiesa Fuxench, Julie K Block, Mark Boguniewicz, et al.
The British Journal of Dermatology|September 9, 2022
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trialsEric L Simpson, Joseph F Merola, Jonathan I Silverberg, et al.
Clinical and Experimental Dermatology|November 9, 2025
Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitisJonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 11, 2024
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitisJonathan I Silverberg, Melinda Gooderham, Norito Katoh, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Prevalence of and association between atopic dermatitis and food sensitivity, food allergy and challenge-proven food allergy: A systematic review and meta-analysisM O Christensen, Y A Barakji, N Loft, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 17, 2021
Association of Varying Clinical Manifestations and Positive Anti-SARS-CoV-2 IgG Antibodies: A Cross-Sectional Observational StudyJonathan I Silverberg, Israel Zyskind, Hiam Naiditch, et al.
The Journal of Allergy and Clinical Immunology|December 29, 2023
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001)Jonathan I Silverberg, Bruce Strober, Brian Feinstein, et al.
Pageof 63